Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The StreetSweeper is an investigative financial research firm that specializes in identifying and reporting on publicly traded companies with questionable business practices, often focusing on the life sciences and biotechnology sectors. The organization is well-known for its critical reports on biotech stocks, frequently highlighting issues such as clinical trial failures, regulatory hurdles, and aggressive promotional tactics. By providing deep-dive analysis and investigative journalism, The StreetSweeper aims to expose what it considers to be overvalued or fraudulent entities to protect retail investors. Its reports have historically had significant impacts on the market valuation of the companies it covers, leading to both high-profile controversies and legal challenges from the targeted firms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Streetsweeper.